(Q28481485)

English

Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data

scientific article

In more languages

Statements

scholarly article

0 references

0 references

Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data (English)

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

François Pattou

11

0 references

Guillaume Lassailly

object named as

Guillaume Lassailly

2

0 references

object named as

Pierre Bedossa

13

0 references

Philippe Mathurin

object named as

Philippe Mathurin

14

0 references

Thierry Poynard

object named as

Thierry Poynard

1

0 references

object named as

Mona Munteanu

7

0 references

Karine Clément

4

object named as

Karine Clement

0 references

15

object named as

Vlad Ratziu

0 references

8

object named as

Hugo Perazzo

0 references

Frédéric Charlotte

12

object named as

Frederic Charlotte

0 references

6

object named as

Joan Tordjman

0 references

author name string

Emmanuel Diaz

3

0 references

Robert Caïazzo

5

0 references

Bernard Demol

9

0 references

Robert Callafe

10

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

3

0 references

e30325

0 references

copyright license

Creative Commons Attribution 4.0 International

14 March 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

FibroTest-ActiTest as a non-invasive marker of liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

19 March 2017

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

19 March 2017

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

19 March 2017

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

19 March 2017

Liver fibrosis in overweight patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

19 March 2017

Steatohepatitis: a tale of two "hits"?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

7 April 2017

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

7 April 2017

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Non-invasive diagnostic tests for non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Non-invasive diagnosis of steatosis and fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Diagnosis and quantitation of fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

External validation of a measurement tool to assess systematic reviews (AMSTAR).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303768

29 September 2017

Non-invasive assessment of liver fibrosis: are we ready?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030325

21 January 2018

How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030325

21 January 2018

ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030325

21 January 2018

A comparison of fibrosis progression in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030325

21 January 2018

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030325

21 January 2018

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030325

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030325

21 January 2018

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030325

21 January 2018

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030325

21 January 2018

Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22431959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22431959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/22431959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard

1 reference

https://pubmed.ncbi.nlm.nih.gov/22431959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0030325

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2012PLoSO...730325P

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28481485&oldid=1951035135"